News › Clinical Practice, Industry News, Patient Care

Study Suggests High Sun Climates Impact Glabellar Botox Dosage Requirements

July 25, 2024
Sun tanning

A comparative cohort study published in the journal Plastic and Reconstructive Surgery examined the effect of climate on the dosage requirements for botulinum toxin A to the glabella.

The low sun exposure center included 231 patients (women aged 35 to 60 years) who received treatment in the United Kingdom during the winter months. The high sun exposure center included 292 patients from the same age demographic who received treatment in the Malta summer months.

A multivariable analysis showed that the low-sun group had lower total dose requirements, with mean total doses (in units) significantly higher in the high-sun group. Researchers conclude that patients injected with botulinum toxin A to the glabella in high-sun climates may have significantly increased dose requirements to achieve maximal paralysis.

Read more at Plastic and Reconstructive Surgery >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
    • MedSafe Becomes Gold Vendor Affiliate with the American Med Spa Association
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics